| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.008 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.01 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |